| Literature DB >> 31779167 |
Enzo Spisni1, Veronica Imbesi2, Elisabetta Giovanardi2, Giovannamaria Petrocelli1, Patrizia Alvisi3, Maria Chiara Valerii2.
Abstract
Although ancient, heritage, and modern wheat varieties appear rather similar from a nutritional point of view, having a similar gluten content and a comparable toxicity linked to their undigested gluten peptide, whenever the role of ancient end heritage wheat grains has been investigated in animal studies or in clinical trials, more anti-inflammatory effects have been associated with the older wheat varieties. This review provides a critical overview of existing data on the differential physiological responses that could be elicited in the human body by ancient and heritage grains compared to modern ones. The methodology used was that of analyzing the results of relevant studies conducted from 2010 through PubMed search, by using as keywords "ancient or heritage wheat", "immune wheat" (protein or peptides), and immune gluten (protein or peptides). Our conclusion is that, even if we do not know exactly which molecular mechanisms are involved, ancient and heritage wheat varieties have different anti-inflammatory and antioxidant proprieties with respect to modern cultivars. It is, therefore, reasonable to assume that the health proprieties attributed to older cultivars could be related to wheat components which have positive roles in the modulation of intestinal inflammation and/or permeability.Entities:
Keywords: amylase trypsin inhibitors (ATI); ancient and heritage wheat; celiac disease; gliadins; gluten; immunogenic wheat peptides
Mesh:
Substances:
Year: 2019 PMID: 31779167 PMCID: PMC6950659 DOI: 10.3390/nu11122879
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Figure 1Flour quality, gluten strength (W), obtainable products, and protein content according to the parameters conventionally required by the food industry. Based on this classification, ancient and heritage wheat flours, obtained in organic farming, would not be suitable for baking since their W is commonly less than 90.
Human intervention trials on ancient or heritage cultivars performed on healthy or diseased subjects.
| Inclusion Criteria | Experimental Design | No. of Subject Enrolled | Ancient/Heritage Wheat Varieties | Control Wheat | Duration of Intervention | Recorded Effects | Ref. |
|---|---|---|---|---|---|---|---|
| Type 2 Diabetes Mellitus. | Randomized, parallel groups. Enrolled patients were randomized to follow an ancient/heritage grain-based diet or a modern grain-based diet. | Whole grain flour: | Whole grain flour: | 6 weeks. | Decreased blood total cholesterol, triglycerides, and LDL-cholesterol. | [ | |
| Healthy subjects. | Open label. | One single meal test. | Decreased Gastric Inhibitory Peptide (GIP) with einkorn bread. | [ | |||
| Healthy subjects. | Non-blinded, crossover. Enrolled patients were randomized to follow a heritage grain-based diet or a modern grain-based diet. | Semi-Whole grain: | Semi-Whole grain: | 10 weeks of diet intervention. | Decreased blood total cholesterol, LDL-cholesterol, IL-8, whole blood viscosity. | [ | |
| Baker’s asthma or wheat allergy. | Interventional open label: Oral and bronchial challenges, prick test. | Immediate. | Decrease of wheal area and percentage of positive challenge tests. | [ | |||
| Healthy subjects. | Randomized, single blind, crossover. | Semi-Whole grain: | Mix of semi-Whole grain: | 8 weeks diet intervention. | Decrease of blood total cholesterol, LDL-cholesterol, glucose, TNFα, IL-6, IL-12, and Vascular endothelial growth factor (VEGF). | [ | |
| Healthy subjects. | Randomized, single-blinded, crossover trial. | Semi-whole grain: | Mixed modern semi-whole grain | 10 weeks diet intervention. | Decrease of total cholesterol, whole blood viscosity, and Red Blood Cell deformability. | [ | |
| Celiac Disease (CD) patients. | Single blind, crossover trial. | Amygluten (pure gluten) and rice. | Administration of a single dose. | No significant conclusions. | [ | ||
| Irritable Bowel Syndrome (IBS) patients | Randomized, double-blinded, crossover trial. | Semi whole grain: | Modern Italian durum and soft wheat varieties. | 6 weeks diet intervention. | Decrease in the severity of IBS symptoms (abdominal pain, bloating, stool consistency, and tiredness). Decrease of IL-6, IL-17, Interferon gamma (IFN-γ), Monocyte chemoattractant protein 1 (MCP-1), VEGF. | [ | |
| Healthy subjects. | Parallel arms. | Whole grain | whole grain: | 3 months. | Increase of short chain fatty acids (SCFA), phenol compounds and an increase in health-promoting mutualists in the gut microbiota. | [ | |
| Type 2 Diabetes Mellitus. | Randomized, double blind, crossover. | Semi-whole grain: | Mix of semi-whole grain: | 8 weeks diet intervention. | Decrease of blood total and LDL cholesterol, insulin and fasting glucose. Decreased levels of reactive oxygen species (ROS), VEGF, and IL-1ra. | [ | |
| Acute Coronary Syndrome. | Randomized, double-blinded, crossover trial. | Semi whole grain: | Mix of semi-whole grain: | 8 weeks diet intervention. | Decrease of blood total cholesterol, LDL-cholesterol, fasting glucose, insulin ROS, and TNF-α. | [ | |
| Healthy young athletes. | Randomized, single-blind crossover trial. | Semi whole grain: | Semi-whole grain: | 4 weeks diet intervention. | Decrease of MCP–1 and improvement of self–rated health status. | [ | |
| CD patients in remission and in GFD diet. | Phase II, open label. | None. | 60 days. | Increased villous atrophy and recurrence of dermatitis herpetiformis. | [ | ||
| Healthy subjects. | Randomized, double-blinded, crossover trial. | 8 weeks diet intervention. | Decrease of blood total cholesterol, LDL-cholesterol, and fasting glucose. | [ | |||
| Pre-hypertensive non diabetic adult volunteers with no metabolic, cardiovascular, gastrointestinal, nor endocrine major disorders. | Double-blind, randomized, feeding-controlled, crossover. | Mix of | 4 weeks diet intervention. | Decrease of blood triglycerides, fasting glucose, systolic blood pressure, and rise of pulse volume change. | [ | ||
| Nonalcoholic Fatty Liver Disease (NAFLD)—mild to moderate liver steatosis—NO, excessive | Randomized, double-blinded trial with two parallel arms. | Semi whole grain: | Mix of semi-whole grain: | 3 months. | Decrease of alanine aminotransferase (ALT), aspartate aminotransferase (AST), TNF-a, IL-1ra, IL-8, and IFN-γ. | [ | |
| Healthy subjects. | Randomized, non-blind, parallel arm study. Enrolled patients were randomized 1:1 to follow an ancient/heritage grain-based diet or a modern grain-based diet. | Whole grain: | Mix of whole grain modern commercial Italian durum wheat. | 16 weeks. | Decrease of fat mass and blood insulin; increase of docosahexaenoic acid (DHA). | [ |